- Home
- / iRhythm Technologies
iRhythm Technologies
Stock Price
$93.5
2023-09-19
Market Capitalization
$2.9 B
2023-09-19
Revenue
$410.9 M
FY, 2022
iRhythm Technologies Summary
Company Summary
- Overview
- iRhythm Technologies is a digital healthcare company. It develops biosensing technology based on cloud-based data analytics and machine learning. The company offers Zio, a platform for early heart disease diagnostics.
- Type
- Public
- Status
- Active
- Founded
- 2006
- HQ
- San Francisco, CA, US | view all locations
- Website
- http://www.irhythmtech.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Douglas Devine, Chief Financial Officer
Allan Wilsker, Executive Vice President of Information Technology and Customer Service
Judy Lenane, Executive Vice President, Products and Chief Clinical Officer
LocationsView all
5 locations detected
San Francisco, CA HQ
United States
699 8th St # 600, San Francisco
Cypress, CA
United States
11085 Knott Ave
Houston, TX
United States
5775 North Sam Houston Parkway West, Suite 200
Lincolnshire, IL
United States
2 Marriott Dr
London, England
United Kingdom
Seal House, 1 Swan Ln, Bridge
iRhythm Technologies Financials
Summary Financials
- Revenue (Q2, 2023)
- $124.1M
- Gross profit (Q2, 2023)
- $86.2M
- Net income (Q2, 2023)
- ($18.5M)
- Cash (Q2, 2023)
- $61.6M
- EBIT (Q2, 2023)
- ($18.9M)
- Enterprise value
- $2.8B